{
  "resourceType" : "ValueSet",
  "id" : "hiv-c-de113",
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Include these codes as defined in <a href=\"CodeSystem-concept-codes.html\"><code>http://fhir.org/guides/itech-uw/who-smart-hiv-dak/CodeSystem/concept-codes</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-concept-codes.html#concept-codes-HIV.46C.46DE113\">HIV.C.DE113</a></td><td>Tenofovir disoproxil fumarate (TDF) allergy or contraindication</td><td>Contraindications to PrEP usage - Tenofovir disoproxil fumarate (TDF) allergy or contraindication</td></tr><tr><td><a href=\"CodeSystem-concept-codes.html#concept-codes-HIV.46C.46DE114\">HIV.C.DE114</a></td><td>HIV-positive</td><td>Contraindications to PrEP usage - HIV-positive</td></tr><tr><td><a href=\"CodeSystem-concept-codes.html#concept-codes-HIV.46C.46DE115\">HIV.C.DE115</a></td><td>Low estimated creatinine clearance</td><td>Contraindications to PrEP usage - Low estimated creatinine clearance</td></tr><tr><td><a href=\"CodeSystem-concept-codes.html#concept-codes-HIV.46C.46DE116\">HIV.C.DE116</a></td><td>Acute HIV infection symptoms</td><td>Contraindications to PrEP usage - Acute HIV infection symptoms</td></tr><tr><td><a href=\"CodeSystem-concept-codes.html#concept-codes-HIV.46C.46DE117\">HIV.C.DE117</a></td><td>Probable recent exposure to HIV</td><td>Contraindications to PrEP usage - Probable recent exposure to HIV</td></tr><tr><td><a href=\"CodeSystem-concept-codes.html#concept-codes-HIV.46C.46DE118\">HIV.C.DE118</a></td><td>Other allergy or contraindication to a medicine in the PrEP regimen</td><td>Contraindications to PrEP usage - Other allergy or contraindication to a medicine in the PrEP regimen</td></tr></table></li></ul></div>"
  },
  "url" : "http://fhir.org/guides/itech-uw/ValueSet/hiv-c-de113",
  "version" : "0.3.0",
  "name" : "ContraindicationstoPrEPusageCodes",
  "title" : "Contraindications to PrEP usage Codes",
  "status" : "draft",
  "experimental" : false,
  "date" : "2024-05-28T18:56:02+00:00",
  "publisher" : "World Health Organization (WHO) ",
  "contact" : [{
    "telecom" : [{
      "system" : "url",
      "value" : "https://www.who.int"
    }]
  }],
  "description" : "Codes representing possible values for the Contraindications to PrEP usage element",
  "jurisdiction" : [{
    "coding" : [{
      "system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
      "code" : "001"
    }]
  }],
  "immutable" : true,
  "compose" : {
    "include" : [{
      "system" : "http://fhir.org/guides/itech-uw/who-smart-hiv-dak/CodeSystem/concept-codes",
      "concept" : [{
        "code" : "HIV.C.DE113",
        "display" : "Tenofovir disoproxil fumarate (TDF) allergy or contraindication"
      },
      {
        "code" : "HIV.C.DE114",
        "display" : "HIV-positive"
      },
      {
        "code" : "HIV.C.DE115",
        "display" : "Low estimated creatinine clearance"
      },
      {
        "code" : "HIV.C.DE116",
        "display" : "Acute HIV infection symptoms"
      },
      {
        "code" : "HIV.C.DE117",
        "display" : "Probable recent exposure to HIV"
      },
      {
        "code" : "HIV.C.DE118",
        "display" : "Other allergy or contraindication to a medicine in the PrEP regimen"
      }]
    }]
  }
}